Literature DB >> 26801076

Presynaptic P2X1-3 and α3-containing nicotinic receptors assemble into functionally interacting ion channels in the rat hippocampus.

Ricardo J Rodrigues1, Teresa Almeida2, Miguel Díaz-Hernández3, Joana M Marques4, Rafael Franco5, Carles Solsona6, María Teresa Miras-Portugal3, Francisco Ciruela7, Rodrigo A Cunha8.   

Abstract

Previous studies documented a cross-talk between purinergic P2X (P2XR) and nicotinic acetylcholine receptors (nAChR) in heterologous expression systems and peripheral preparations. We now investigated if this occurred in native brain preparations and probed its physiological function. We found that P2XR and nAChR were enriched in hippocampal terminals, where both P2X1-3R and α3, but not α4, nAChR subunits were located in the active zone and in dopamine-β-hydroxylase-positive hippocampal terminals. Notably, P2XR ligands displaced nAChR binding and nAChR ligands displaced P2XR binding to hippocampal synaptosomes. In addition, a negative P2XR/nAChR cross-talk was observed in the control of the evoked release of noradrenaline from rat hippocampal synaptosomes, characterized by a less-than-additive facilitatory effect upon co-activation of both receptors. This activity-dependent cross-inhibition was confirmed in Xenopus oocytes transfected with P2X1-3Rs and α3β2 (but not α4β2) nAChR. Besides, P2X2 co-immunoprecipitated α3β2 (but not α4β2) nAChR, both in HEK cells and rat hippocampal membranes indicating that this functional interaction is supported by a physical association between P2XR and nAChR. Moreover, eliminating extracellular ATP with apyrase in hippocampal slices promoted the inhibitory effect of the nAChR antagonist tubocurarine on noradrenaline release induced by high- but not low-frequency stimulation. Overall, these results provide integrated biochemical, pharmacological and functional evidence showing that P2X1-3R and α3β2 nAChR are physically and functionally interconnected at the presynaptic level to control excessive noradrenergic terminal activation upon intense synaptic firing in the hippocampus.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ATP (PubChem CID:5957); Cytisine (PubChem CID:10235); DHβE (PubChem CID:31762); Epibatidine (PubChem CID:3073763); Hippocampus; Methyllycaconitine (PubChem CID:5288811); NF023 (PubChem CID:4465); Neuromodulation; Nicotine (PubChem CID:942); Nicotinic receptors; Noradrenaline; P2X receptors; PPADS (PubChem CID:6093163); Presynaptic; Tubocurarine (PubChem CID:6000); α,β-methylene ATP (PubChem CID:91557)

Mesh:

Substances:

Year:  2016        PMID: 26801076     DOI: 10.1016/j.neuropharm.2016.01.022

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

Review 1.  P2X receptors.

Authors:  R Alan North
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-08-05       Impact factor: 6.237

2.  Heteroreceptor Complexes Formed by Dopamine D1, Histamine H3, and N-Methyl-D-Aspartate Glutamate Receptors as Targets to Prevent Neuronal Death in Alzheimer's Disease.

Authors:  Mar Rodríguez-Ruiz; Estefanía Moreno; David Moreno-Delgado; Gemma Navarro; Josefa Mallol; Antonio Cortés; Carme Lluís; Enric I Canela; Vicent Casadó; Peter J McCormick; Rafael Franco
Journal:  Mol Neurobiol       Date:  2016-07-01       Impact factor: 5.590

3.  Glutamate-induced and NMDA receptor-mediated neurodegeneration entails P2Y1 receptor activation.

Authors:  Ana P Simões; Carla G Silva; Joana M Marques; Daniela Pochmann; Lisiane O Porciúncula; Sofia Ferreira; Jean P Oses; Rui O Beleza; Joana I Real; Attila Köfalvi; Ben A Bahr; Juan Lerma; Rodrigo A Cunha; Ricardo J Rodrigues
Journal:  Cell Death Dis       Date:  2018-02-20       Impact factor: 8.469

Review 4.  Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update.

Authors:  Guendalina Olivero; Matteo Vergassola; Francesca Cisani; Alessandra Roggeri; Anna Pittaluga
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 5.  Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.

Authors:  Júlia Leão Batista Simões; Julia Beatrice de Araújo; Margarete Dulce Bagatini
Journal:  Mol Neurobiol       Date:  2021-07-11       Impact factor: 5.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.